Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
Molecular Markers Predict Tumor Recurrence
June 18th, 2007
Researchers at the University of Southern California (USC) have identified specific molecular markers that may help to predict tumor recurrence in stage II and III colon cancer patients. The findings may also help identify stage II colon cancer patients who are more likely to benefit from adjuvant chemotherapy following surgery, says Georg Lurje M.D., research associate at the Keck School of Medicine of the University of Southern California (USC). The study was presented Tuesday, June 5 at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held at McCormick Place in Chicago. For patients who undergo...
Source: Health & Medicine Week (2007-06-18)
|
